Stay updated on Imsidolimab for Palmoplantar Pustulosis Clinical Trial
Sign up to get notified when there's something new on the Imsidolimab for Palmoplantar Pustulosis Clinical Trial page.

Latest updates to the Imsidolimab for Palmoplantar Pustulosis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange Detected- Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference4%
- Check24 days agoChange DetectedCore content refocused to the term 'Palmoplantar pustulosis' with an updated revision: v3.1.0, and several older or broader drug-safety topics removed (e.g., 'Pustulosis palmaris et plantaris', 'Counterfeit Drugs', 'Substandard Drugs', 'Pharmaceutical Preparations'), plus the old revision tag v3.0.2 deleted.SummaryDifference0.7%
- Check31 days agoChange DetectedUpdated study sponsor and timeline; added Vanda Pharmaceuticals and new dates, with a note that the study has 39 locations, replacing a broad list of previous sites and investigators.SummaryDifference14%
- Check38 days agoChange DetectedUpdated the page to Revision: v3.0.2, replacing the previous v3.0.1 and removing the Back to Top element.SummaryDifference0.2%
- Check45 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.2%
- Check52 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations, as well as resources related to genetic and rare diseases. Notably, the page has been revised to version 3.0.0.SummaryDifference9%
Stay in the know with updates to Imsidolimab for Palmoplantar Pustulosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Imsidolimab for Palmoplantar Pustulosis Clinical Trial page.